Ramelteon Tablets are used to treat insomnia that is associated with having trouble falling asleep. As per IQVIA health data, the medication has a projected market size of US$91.3 million in the 12-month period ending May 2019 in the US markets.

The following stocks would be in focus during Wednesday’s trading session in light of their results announcement: Asian Paints, Canara Bank, Crompton Greaves Consumer Electricals, Jubilant FoodWorks and PI Industries

Can Fin Homes recorded a quarterly net profit of Rs. 80.98 crores for the June quarter of FY20. The company's net profit was up by 20.85 per cent on QoQ basis and 10.59 per cent up on YoY basis.

Before closing a deal or starting any activity going through a checklist helps us make sure everything is in place and okay. So, what are the things that you must check before investing in debt funds? Let’s find out.

VA Tech Wabag has bagged order worth Rs. 1,187 crore from Bihar Urban Infrastructure Development Corporation (BUIDCO). The order falls under the prestigious National Mission for Clean Ganga (NMCG) Scheme.

The apex court orders the cancellation of the RERA registration of Amrapali Group and directs ED to investigate the company for money laundering. State-owned real estate developer NBCC India was appointed by the Supreme Court (SC) to complete the unfinished projects taken up by the builder.

Following stocks are close to their 52-weeks low as at 12:49 p.m. on July 23, 2019.

The markets on July 23, 2019 opened gap down. BSE Sensex is trading at 38,097.54, up by 66.41 points and the Nifty is trading at 11,348.15, up by 1.95 points. 

The order would further expand the company’s EMP and Packaged Air Conditioning system segment revenue, going ahead. The order book of EMP and Packaged Air Conditioning system segment as on FY19 stood at Rs. 2,952 core which translates book-to-bill of 1.1x on FY19 revenue giving healthy revenue visibility in the near term.

Gujarat-based pharmaceutical company Alembic Pharma today informed the bourses that it has received tentative approval from US Food & Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg.